VKTX Return on Tangible Equity | Viking Therapeutics, Inc.

Viking Therapeutics, Inc. (VKTX) Return on Tangible Equity

2026-06-30: Return Tang Equity -130.98%.
2026-03-31: Return Tang Equity -94.11%.
2025-12-31: Return Tang Equity -56.28%.
2025-09-30: Return Tang Equity -33.29%.

Complete source-backed return tang equity history.

Available history: 2014-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-130.98%
2026-03-31	-94.11%
2025-12-31	-56.28%
2025-09-30	-33.29%
2025-06-30	-21.57%
2025-03-31	-15.14%
2024-12-31	-12.49%
2024-09-30	-10.88%
2024-06-30	-10.50%
2024-03-31	-10.04%
2023-12-31	-24.65%
2023-09-30	-21.96%
2023-06-30	-19.19%
2023-03-31	-53.93%
2022-12-31	-47.39%
2022-09-30	-40.76%
2022-06-30	-35.79%
2022-03-31	-31.32%
2021-12-31	-27.24%
2021-09-30	-25.14%
2021-06-30	-22.06%
2021-03-31	-18.47%
2020-12-31	-16.16%
2020-09-30	-14.18%
2020-06-30	-12.38%
2020-03-31	-11.38%
2019-12-31	-9.30%
2019-09-30	-8.31%
2019-06-30	-8.47%
2019-03-31	-7.96%
2018-12-31	-7.41%
2018-09-30	-6.92%
2018-06-30	-14.54%
2018-03-31	-26.03%
2017-12-31	-152.84%
2017-09-30	-904.67%
2017-06-30	-270.89%
2017-03-31	-216.89%
2016-12-31	-183.17%
2016-09-30	-158.31%
2016-06-30	-133.80%
2016-03-31	-368.81%
2015-12-31	-268.24%
2015-09-30	-127.53%
2015-06-30	-71.57%
2015-03-31	98.30%
2014-12-31	98.90%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-56.28%
2024-12-31	-12.49%
2023-12-31	-24.65%
2022-12-31	-47.39%
2021-12-31	-27.24%
2020-12-31	-16.16%
2019-12-31	-9.30%
2018-12-31	-7.41%
2017-12-31	-152.84%
2016-12-31	-183.17%
2015-12-31	-268.24%
2014-12-31	98.90%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Indivior Pharmaceuticals, Inc. (INDV)		$4.250B	14.09
Tango Therapeutics, Inc. (TNGX)	United States	$4.154B	-42.53
Edgewise Therapeutics, Inc. (EWTX)	United States	$4.470B	-22.23
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59
ACADIA PHARMACEUTICALS INC (ACAD)	United States	$3.823B	11.45
Veradermics, Inc (MANE)	United States	$4.839B
Xenon Pharmaceuticals Inc. (XENE)		$3.684B	-14.27
Organon & Co. (OGN)	United States	$3.603B	17.03
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96